A detailed history of Money Concepts Capital Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Money Concepts Capital Corp holds 33,606 shares of AZN stock, worth $2.23 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
33,606
Previous 34,678 3.09%
Holding current value
$2.23 Million
Previous $2.7 Million 3.18%
% of portfolio
0.21%
Previous 0.24%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$76.67 - $87.62 $82,190 - $93,928
-1,072 Reduced 3.09%
33,606 $2.62 Million
Q2 2024

Aug 02, 2024

SELL
$66.81 - $80.83 $91,663 - $110,898
-1,372 Reduced 3.81%
34,678 $2.7 Million
Q1 2024

May 01, 2024

BUY
$61.03 - $69.57 $10,314 - $11,757
169 Added 0.47%
36,050 $2.44 Million
Q4 2023

Feb 12, 2024

BUY
$61.89 - $69.28 $44,560 - $49,881
720 Added 2.05%
35,881 $2.42 Million
Q3 2023

Oct 31, 2023

BUY
$64.85 - $71.7 $76,263 - $84,319
1,176 Added 3.46%
35,161 $2.38 Million
Q2 2023

Jul 31, 2023

SELL
$69.91 - $75.81 $21,042 - $22,818
-301 Reduced 0.88%
33,985 $2.43 Million
Q1 2023

May 01, 2023

SELL
$63.15 - $71.6 $312,276 - $354,062
-4,945 Reduced 12.6%
34,286 $2.38 Million
Q4 2022

Feb 14, 2023

BUY
$54.21 - $70.44 $127,176 - $165,252
2,346 Added 6.36%
39,231 $2.66 Million
Q3 2022

Oct 27, 2022

BUY
$53.02 - $135.75 $87,960 - $225,209
1,659 Added 4.71%
36,885 $2.02 Million
Q2 2022

Jul 18, 2022

SELL
$59.26 - $71.14 $185,365 - $222,525
-3,128 Reduced 8.16%
35,226 $2.32 Million
Q1 2022

May 13, 2022

BUY
$55.72 - $67.12 $189,336 - $228,073
3,398 Added 9.72%
38,354 $2.54 Million
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $100,747 - $119,042
-1,865 Reduced 5.07%
34,956 $2.04 Million
Q1 2021

May 17, 2021

BUY
$47.16 - $54.44 $1.55 Million - $1.78 Million
32,769 Added 808.71%
36,821 $1.83 Million
Q4 2020

May 17, 2021

BUY
$48.52 - $58.02 $196,603 - $235,097
4,052 New
4,052 $203,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Money Concepts Capital Corp Portfolio

Follow Money Concepts Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Money Concepts Capital Corp with notifications on news.